Crown ElectroKinetics (NASDAQ:CRKN) reported quarterly losses of $(0.18) per share. This is a 53.85 percent increase over losses of $(0.39) per share from the same period last year.
ADMA Biologics: Earnings Outlook
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Analysts estimate that ADMA Biologics will report an earnings per share (EPS) of $-0.08.